Simposi
On The Bright And The Dark Side Of Amyloid Beta: Looking Over Alzheimer's Disease
26 ottobre 2017 / 14.00-16.00
| 65 |
b-Amyloid and cell cycle activation in Alzheimer’s disease: perspectives for drug development Filippo Caraci (Catania) |
| 66 |
Neuroinflammation and Alzheimer’s disease: towards multi-target therapies Claudia Balducci (Milan) |
| 67 |
Soluble beta amyloid as bridge between Depression and Alzheimer’s disease: evidences from an animal model Maria Grazia Morgese (Foggia) |
| 68 |
Targeting pathologic amyloid without perturbing amyloid physiological activity Stefano Govoni (Pavia) |